Table 8.
First treatment for patients compliant to NCCS guidelines staged by HKLC guidelines
| HKLC stage | First treatment at Singhealth Institutions |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| resection, N = 82 | RFA, N = 46 | SIRT, N = 89 | radiotherapy, N = 4 | TACE, N = 14 | sorafenib, N = 76 | other systemic therapy, N = 43 | clinical trials, N = 78 | combination therapy, N = 4 | best supportive care, N = 22 | |
| 1 (N = 123) | 72 | 45 | 2 (TSM) | 1 (TSM) | 3 (TSM) | |||||
| 2 (N = 61) | 9 |
25 (TSM) 5 |
8 (TSM) 2 |
4 (TSM) 1 |
5 (TSM) 2 |
|||||
| 3 (N = 100) | 1 (TSM) | 53 | 2 (TSM) | 3 |
11 (TSM) 3 |
5 (TSM) 2 |
8 (TSM) 12 |
|||
| 4 (N = 138) | 3 | 1 | 53 | 30 | 47 | 4 (systemic + y90) | ||||
| 5 (N = 36) | 1 | 1 | 1 | 4 | 6 | 1 | 22 | |||
Italicized: number of patients undergoing HKLC compliant treatments. TSM, treatment stage migration; HKLC, Hong Kong Liver Cancer; SIRT, selective internal radiation therapy; NCCS, National Cancer Centre Singapore.